Cargando…

Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene

Partner and localizer of BRCA2 (PALB2) interacts with BRCA2 to enable double strand break repair through homologous recombination. Similar to BRCA2, germline mutations in PALB2 have been shown to predispose to Fanconi anaemia as well as pancreatic and breast cancer. The PALB2/BRCA2 protein interacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoude, Lauren G., Xu, Mai, Zhao, Zhen Zhen, Kovacs, Michael, Palmer, Jane M., Johansson, Peter, Symmons, Judith, Trent, Jeffrey M., Martin, Nicholas G., Montgomery, Grant W., Brown, Kevin M., Hayward, Nicholas K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065098/ https://www.ncbi.nlm.nih.gov/pubmed/24949998 http://dx.doi.org/10.1371/journal.pone.0100683

Ejemplares similares

Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers
por: Pritchard, Antonia L., et al.
Publicado: (2018)

Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4
por: Johansson, Peter, et al.
Publicado: (2015)

POT1 loss-of-function variants predispose to familial melanoma
por: Robles-Espinoza, Carla Daniela, et al.
Publicado: (2014)

A BAP1 Mutation in a Danish Family Predisposes to Uveal Melanoma and Other Cancers
por: Aoude, Lauren G., et al.
Publicado: (2013)

Multiplex melanoma families are enriched for polygenic risk
por: Law, Matthew H, et al.
Publicado: (2020)

Evidence against PALB2 involvement in Icelandic breast cancer susceptibility
por: Gunnarsson, Haukur, et al.
Publicado: (2008)

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
por: Song, Honglin, et al.
Publicado: (2021)

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma
por: Stark, Mitchell S., et al.
Publicado: (2015)

Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
por: Boonen, Rick A. C. M., et al.
Publicado: (2019)

Tumour morphology predicts PALB2 germline mutation status
por: Teo, Z L, et al.
Publicado: (2013)

Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian population
por: Hilz, Philip, et al.
Publicado: (2019)

Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2
por: Wu, Shijie, et al.
Publicado: (2022)

Hi-Plex for high-throughput mutation screening: application to the breast cancer susceptibility gene PALB2
por: Nguyen-Dumont, Tú, et al.
Publicado: (2013)

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
por: Yokoyama, Satoru, et al.
Publicado: (2011)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
por: Hu, Zhe-Yu, et al.
Publicado: (2020)

Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in Melanoma
por: Bonazzi, Vanessa F., et al.
Publicado: (2011)

From GWAS to genome sequencing: complementary approaches to identify melanoma predisposition genes
por: MacGregor, S, et al.
Publicado: (2012)

Meta-analysis combining new and existing data sets confirms that the TERT-CLPTM1L locus influences melanoma risk
por: Law, Matthew H., et al.
Publicado: (2011)

PALB2 (partner and localizer of BRCA2)
por: Hanenberg, Helmut, et al.
Publicado: (2018)

BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study
por: Zhen, David B., et al.
Publicado: (2014)

Choroidal melanoma with synchronous Fuchs’ adenoma and novel ATRX mutation
por: Harford, Elli, et al.
Publicado: (2022)

The PALB2 DNA-binding domain is an intrinsically disordered recombinase
por: Kyriukha, Yevhenii, et al.
Publicado: (2023)

The PALB2 DNA-binding domain is an intrinsically disordered recombinase
por: Kyriukha, Yevhenii, et al.
Publicado: (2023)

The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
por: Nepomuceno, Thales C., et al.
Publicado: (2017)

PALB2 and breast cancer: ready for clinical translation!
por: Southey, Melissa C, et al.
Publicado: (2013)

PALB2 self-interaction controls homologous recombination
por: Buisson, Rémi, et al.
Publicado: (2012)

A PALB2 mutation associated with high risk of breast cancer
por: Southey, Melissa C, et al.
Publicado: (2010)

PALB2 mutations in German and Russian patients with bilateral breast cancer
por: Bogdanova, Natalia, et al.
Publicado: (2010)

Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3
por: MacGregor, Stuart, et al.
Publicado: (2011)

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls
por: Thompson, Ella R., et al.
Publicado: (2015)

Enhancement of the RAD51 Recombinase Activity by the Tumor Suppressor PALB2
por: Dray, Eloïse, et al.
Publicado: (2010)

Functional characterization of 84 PALB2 variants of uncertain significance
por: Wiltshire, Timothy, et al.
Publicado: (2019)

Structural Insight into the Mechanism of PALB2 Interaction with MRG15
por: Redington, Jennifer, et al.
Publicado: (2021)

Evolutionary Origin of Human PALB2 Germline Pathogenic Variants
por: Chian, Jia Sheng, et al.
Publicado: (2023)

Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer
por: Grant, Robert C, et al.
Publicado: (2013)

Meta-Analysis of Breast Cancer Risk for Individuals with PALB2 Pathogenic Variants
por: Ruberu, Thanthirige Lakshika M., et al.
Publicado: (2023)

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses
por: Ng, Pei Sze, et al.
Publicado: (2021)

Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
por: Teo, Zhi L, et al.
Publicado: (2013)

Functional Characterization of PALB2 Variants of Uncertain Significance: Toward Cancer Risk and Therapy Response Prediction
por: Boonen, Rick A. C. M., et al.
Publicado: (2020)

Perturbation of PALB2 function by the T413S mutation found in small cell lung cancer
por: Bleuyard, Jean-Yves, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jjmuhsq8s0f7m85b7fnhrgrk6s